News

The models in this latter group, all young and conventionally attractive, were checking a laptop while holding a stack of ...
In an industry where 90 percent of drug candidates fail before reaching the market, a handful of startups are betting ...
According to a recent study, nearly three in four Americans are overweight. Worse, this report predicts that for decades to ...
Today, anthrax remains one of the deadliest and easiest biological weapons to produce. Yet 80 percent of the U.S. supply of ...
As temperatures rise, so does the risk of heat-related illness—especially for people taking certain prescription drugs.
GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan Skrmetti.
Diabetes pills could hit Australian shelves within years, offering an alternative to popular injectable treatments such as Ozempic.
Ozempic in a pill? The next generation of weight-loss drugs emerges Liam Mannix June 29, 2025 — 9.00am Normal text size Larger text size Very large text size ...
WASHINGTON — Jacqueline Corrigan-Curay, the top drug regulator at the Food and Drug Administration, is retiring from the agency in July. Corrigan-Curay, who took over as acting director of the ...
The drugs – glucagon-like peptide-1 (GLP-1) weight-loss medicines – are manufactured and shipped from China, according to the packaging. She orders them through online vendors.
Amgen’s monthly obesity candidate led to substantial weight loss but a high rate of side effects and discontinuations in a mid-stage trial, as the company plans to adjust dosing.
"This drug represents a completely new type of treatment and has the potential to be of great importance for patients with type 2 diabetes and obesity. Our substance appears to promote healthy ...